Moderna (MRNA.US) surged by 100% intraday, with its total market value surpassing $50 billions, as the company and Merck announced successful results in melanoma vaccine research. Merck (MRK.US) rose by 10%, and BioNTech increased by 17.6%.

Moderna (MRNA.US) surged by 100% intraday, with its total market value surpassing $50 billions, as the company and Merck announced successful results in melanoma vaccine research. Merck (MRK.US) rose by 10%, and BioNTech increased by 17.6%.

智通财经2026/08/19 13:46

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Moderna (MRNA.US) intraday surge reaches 100%, with a total market capitalization surpassing 5 billion USD. The company, together with Merck & Co., announced success in melanoma vaccine research. Merck & Co. (MRK.US) rose 10%, and BioNTech gained 17.6%.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Moderna (MRNA.US) surged by 100% intraday, with its total market value surpassing $50 billions, as the company and Merck announced successful results in melanoma vaccine research. Merck (MRK.US) rose by 10%, and BioNTech increased by 17.6%.

You may also like

Crypto prices